PHC-17-2014
PHC-17-2014
8 projects · €44,547,635 total EU contribution (project-level) · 114 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€44,547,635
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (15)
- Spain (14)
- UK (14)
- France (13)
- Germany (11)
- Italy (9)
- HU (4)
- PT (4)
- AT (3)
- BE (3)
- DK (3)
- PL (3)
- CH (2)
- EL (2)
- IE (2)
- NO (2)
- RO (2)
- CZ (1)
- EE (1)
- FI (1)
- HR (1)
- LT (1)
- SE (1)
- SK (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- STICHTING AMSTERDAM UMC3 projects · NL
- ARTTIC2 projects · FR
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 projects · FR
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 projects · DE
- UNIVERSITY OF DEBRECEN DE2 projects · HU
- STICHTING RADBOUD UNIVERSITEIT2 projects · NL
- STICHTING VU2 projects · NL
- UEDIN2 projects · UK
- UNIVERSITAET BERN2 projects · CH
- UMC UTRECHT2 projects · NL
- UNIVERSITY OF GLASGOW2 projects · UK
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly EU-CaRE · 634439 | H2020 | €5,593,049 | €24,857 | Details |
OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly OPERAM · 634238 | H2020 | €3,735,608 | €878,006 | Details |
I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly I-MOVE-plus · 634446 | H2020 | €7,482,729 | €67,112 | Details |
Secondary prEvention of CardiovascUlaR disease in the Elderly trial SECURE · 633765 | H2020 | €5,998,786 | €232,609 | Details |
PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke PRECIOUS · 634809 | H2020 | €5,334,687 | €425,678 | Details |
Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis GLORIA · 634886 | H2020 | €5,855,219 | €1,909,020 | Details |
Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time MDS-RIGHT · 634789 | H2020 | €5,999,998 | €212,938 | Details |
SITless: Exercise Referral Schemes enhanced by Self-Management Strategies to battle sedentary behaviour SITless · 634270 | H2020 | €4,547,560 | €237,078 | Details |